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Rothia muciliaginosa (R. mucilaginosa) is a facultative, Gram-positive coccus that is
considered to be part of the normal ﬂora of the mouth and respiratory tract. There
are sporadic reports of the organism causing endocarditis in patients with heart
valve abnormalities, as well as meningitis, septicemia, and pneumonia associated
with intravenous drug abuse. However, it is an unusual pathogen in cases of
peritoneal dialysis (PD)-associated peritonitis. Although R. mucilaginosa is generally
susceptible to penicillin, ampicillin, cefotaxime, imipenem, rifampicin, and glyco-
peptides, there are no guidelines for the treatment of PD-associated peritonitis.
Herein, we report a case of PD-associated peritonitis due to R. mucilaginosa that was
resolved with intraperitoneal antibiotic treatment.
Copyright & 2015. The Korean Society of Nephrology. Published by Elsevier. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Continuous ambulatory peritoneal dialysis (CAPD) is an
important treatment option for patients with end-stage renal
disease. Although the rate of peritonitis has declined in recent
years because of improvements in CAPD techniques, peritoni-
tis remains the leading cause for discontinuation of CAPD [1].
Rothia muciliaginosa (R. mucilaginosa) is a component of the
normal ﬂora of the mouth and respiratory tract and is usually
associated with dental plaques, cavities, and periodontal dis-
eases [2,3]. It appears that the presence of an indwelling
vascular catheter and previous treatment with ciproﬂoxacin
increase the risk of invasive infection with Rothia [4]. However,
cases of peritonitis caused by R. mucilaginosa are rare. Further-
more, deﬁnitive guidelines do not exist for treating R. mucila-
ginosa–induced peritonitis.15. The Korean Society of Nep
.org/licenses/by-nc-nd/4.0/).
al Medicine, Presbyterian
san-gu, 560-750 Jeonju,
).Although cases of peritoneal dialysis (PD)-associated peri-
tonitis caused by R. mucilaginosa have been reported world-
wide, no Korean cases have been reported [5,6]. To the best of
our knowledge, this is the ﬁrst case report of peritonitis due to
R. mucilaginosa as a single pathogen in Korea. Herein, we
describe a case of PD-associated peritonitis caused by
R. mucilaginosa that was cured after a 2-week course of intra-
peritoneal antibiotic therapy.Case report
A 58-year-old Korean man, who had been treated with
CAPD for 3 years, was admitted to our hospital because of
turbid peritoneal efﬂuent accompanied by constant abdominal
pain that began 1 day before his admission. The underlying
causes of his end-stage renal disease were diabetes mellitus
and hypertension. He had two prior episodes of peritonitis in
the past few years. He exchanged dialysis solutions of 2 L per
dwell 4 times/d, with the solution remaining in the abdomen
for 6 hours and had a urine output of about 200 mL/d.hrology. Published by Elsevier. This is an open access article under the
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rate was 72 beats/min, respiratory rate was 18 breaths/min,
and body temperature was 37.41C. His abdomen was diffusely
tender with normal bowel sounds, and infection was not found
around the catheter exit site. The laboratory ﬁndings showed
PD-associated peritonitis: the white blood cell (WBC) count of
the peritoneal efﬂuent was 1,620/mm3 with a neutrophil
predominance (90%). His hemoglobin was 9.9 g/dL, WBC count
was 14.5 109/L, and C-reactive protein was 12.53 mg/dL
(normal: o0.8 mg/dL). Bacteria were not observed on Gram
stain examination. After the peritoneal ﬂuid was sent for
bacterial culture, a single 1 g/d dose of cefazolin and a single
1 g/d dose of ceftazidime were given intraperitoneally. Two
peritoneal ﬂuid samples were inoculated into a BACTEC plus
Aerobic/F culture bottle (Becton Dickinson Diagnostic Instru-
ment System, Drogheda, Ireland) and incubated in a BacT/
ALERT 3D Blood Culture System (Biomerieux, Marcy l`etoile,
France). Culture of the peritoneal dialysate revealed Strepto-
coccus mitis, which was susceptible to levoﬂoxacin, clindamy-
cin, vancomycin, and tetracycline.
The peritoneal WBC count decreased to 30/mm3, and the
patient's clinical condition improved on the 5th day after
starting intraperitoneal cefazolin and ceftazidime. The patient
recovered after a 2-week course of intraperitoneal antibiotics.
However, he complained of abdominal pain and turbid peri-
toneal efﬂuent 3 days after termination of intraperitoneal
antibiotics. The WBC count of the peritoneal efﬂuents was
2,140/mm3 with a neutrophil predominance (80%). We
restarted intraperitoneal cefazolin and ceftazidime, and
repeated culture of the peritoneal dialysate revealed S. mitis.
According to the International Society for Peritoneal Dialysis
guidelines, we recommended removal of the PD catheter, but
he refused our recommendation. Therefore, we maintained
intraperitoneal antibiotics, and the patient improved after
intraperitoneal antibiotics for 2 weeks; however, the patient
experienced turbid peritoneal efﬂuent 10 days after cessation
of the second round of intraperitoneal antibiotics. The WBC
count of the peritoneal efﬂuents was 2,080/mm3 with a
neutrophil predominance (85%), and repeated culture of the
peritoneal dialysate revealed R. mucilaginosa. The peritoneal
WBC count decreased to 8/mm3, and abdominal pain disap-
peared on the 3rd day after starting intraperitoneal cefazolin
and ceftazidime. The patient's condition improved, and he wasFigure 1. Serial changes of white blood cell count in peritoneal
efﬂuents during hospitalization. Peritoneal white blood cell count
increased up to 3,680/mm3 and recovered to normal levels in a short
time span. R. mucilaginosa, Rothia mucilaginosa; S. mitis, Streptococcus
mitis; WBC, white blood cell.discharged after a 2-week course of intraperitoneal antibiotics
(Fig. 1).
During the admission period, the patient presented with a
painful mass anteriorly over his left clavicle. X-ray showed a
poorly deﬁned, surface-based lesion arising from the proximal
shaft of the left clavicle. Computed tomography scan revealed
osteolytic bony destruction and soft tissue mass formation
suggesting a malignant bone tumor, such as a chondrosarcoma
or osteogenic sarcoma with pathologic fracture in the proximal
portion of the left clavicle (Fig. 2). Although we recommended
further workup and an operation, he refused.Discussion
PD-associated peritonitis caused by R. mucilaginosa is rare,
and this coccus has not been reported as the single causative
pathogen of PD-associated peritonitis in Korea. Here, we
report a case of peritonitis due to R. mucilaginosa that
recovered after intraperitoneal antibiotic therapy. A malignant
bone tumor on the left clavicle was coincidentally found.
R. mucilaginosa is a Gram-positive, coagulase-negative,
encapsulated, non–spore-forming coccus considered part of
the commensal ﬂora of the oral cavity and upper respiratory
tract in humans. Infection in humans was ﬁrst reported as
endocarditis in 1978 [2,3,7]. R. mucilaginosa appears to be an
opportunistic pathogen in immunocompromised patients and
has been implicated in serious infections such as septicemia,
endocarditis, meningitis, pneumonia, and osteomyelitis [4].
However, it is an unusual pathogen in cases of PD-associated
peritonitis. Although cases of PD-associated peritonitis caused
by R. mucilaginosa have been reported previously, there are no
prior reports in Korea. To the best of our knowledge, this is the
ﬁrst case report of PD-associated peritonitis due to R. mucila-
ginosa in Korea.
The most common risk factors for Rothia infection are
indwelling catheter, leukemia, cancer, cardiac valvular heart
disease, intravenous drug abuse, severe neutropenia, and
previous treatment with ciproﬂoxacin [8]. R. mucilaginosa is
usually associated with the formation of dental plaque and
tooth cavities. In our case, the patient did not have any recent
history of dental work; however, he had a history of treatment
with ciproﬂoxacin 2 months earlier and had a malignant bone
tumor on the left clavicle. Therefore, this patient was at highFigure 2. Chest computed tomography scan. The arrow indicates a
malignant bone tumor, such as chondrosarcoma or osteogenic sarcoma,
with an accompanying pathologic fracture on the left clavicle.
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such as Rothia.
Recommendations for treatment of R. mucilaginosa-induced
peritonitis were not included in the International Society for
Peritoneal Dialysis guidelines [9]. However, based on previous
literature, all patients with PD-associated peritonitis caused by
R. mucilaginosa recovered after intraperitoneal antibiotic therapy
including ampicillin, rifampin, vancomycin, and cefazolin [5,6,10].
It was reported that a patient with human immunodeﬁciency
virus was successfully treated with intraperitoneal vancomycin
[11]. Another patient who had recently lost a renal allograft and
was still on immunosuppressive therapy developed coagulase-
negative staphylococcal bacteremia and culture-negative peritoni-
tis treated with ceftriaxone and oﬂoxacin with removal of PD
catheter. Two months later, she was back on PD and had another
episode of peritonitis, which grew R. mucilaginosa. It responded
well to intraperitoneal vancomycin with resolution of symptoms
in 2 days [12]. In our case, we did not perform an antibiotic
sensitivity test because of the absence of Clinical Laboratory
Standard Institute guidelines for this organism [6]. We empirically
started intraperitoneal cefazolin and ceftazidime and maintained
these antibiotics with clinical improvement. Such antibiotics could
be helpful to treat R. mucilaginosa-induced peritonitis if sensitivity
test results are not available.
In summary, we report a case of PD-associated peritonitis
caused by R. mucilaginosa that was cured after a 2-week course
of intraperitoneal antibiotic therapy. Intraperitoneal antibiotics
should therefore be considered as treatment for PD-associated
peritonitis caused by R. mucilaginosa.Conﬂicts of interest
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